PATH
PATH
Explore linked clinical trials.16 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries | AIDS, Blood-Borne Infections, Digestive System Diseases, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, hepatitis, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, liver disorder, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-10-09 | NCT06395129 | |
| Infant Malaria Vaccine Schedule Optimization | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 2 | 2026-09-29 | NCT06879327 | |
| Ethiopian Antimalarial Therapeutic Efficacy Study 2026 | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Not stated | 2026-09-25 | NCT07840898 | |
| FocaL Mass Drug Administration for Vivax Malaria Elimination | Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 3 | 2026-06-09 | NCT05690841 | |
| Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 2 | 2026-05-11 | NCT05654467 | |
| Impact of a Cricket and Black Soldier Fly Larvae-Fortified Cracker on the Gut Microbiome and Iron Status in Malagasy Schoolchildren | Gut -Microbiota; Inflamation; Iron Absorption | Not yet recruiting | Not applicable | 2026-02-27 | NCT07439185 | |
| LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk | Very Low Birthweight; Very Preterm Infant | Recruiting | Not applicable | 2026-01-21 | NCT06765863 | |
| Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 2 | 2026-01-09 | NCT06895486 | |
| Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age. | Bacterial Infections and Mycoses, Group B Streptococcal Infections, Infections, bacterial infectious disease, gram-positive bacterial infections, streptococcal infection | Active, not recruiting | Phase 1 / Phase 2 | 2025-11-18 | NCT06611371 | |
| Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Not yet recruiting | Not stated | 2025-10-07 | NCT06129916 | |
| Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2025-06-03 | NCT06137664 | |
| Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 3 | 2025-05-06 | NCT06516042 | |
| Challenge Non-Typhoidal Salmonella (CHANTS) Study | Bacterial Infections and Mycoses, Digestive System Diseases, Disease Attributes, Enterobacteriaceae Infections, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, digestive system disorder, gastroenteritis, gram-negative bacterial infections, infectious disease, invasive non-typhoidal salmonellosis, salmonellosis, typhoid fever | Active, not recruiting | Not applicable | 2025-05-02 | NCT05870150 | |
| Shigella Sonnei 53G Human Infection Study in Kenyan Adults | Bacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, bacterial infectious disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosis | Recruiting | Phase 1 | 2025-03-13 | NCT05959616 | |
| Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine | Infections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2025-02-28 | NCT05041556 | |
| InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia | Bacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, bacterial infectious disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosis | Recruiting | Phase 1 | 2024-11-07 | NCT05961059 |